The OCEANIC-AF study is looking for patients with atrial fibrillation

Worldwide, ATRIAL FIBRILLATION is one of the most common causes of stroke. Researchers are now exploring the use of an investigational drug in patients with atrial fibrillation.

Worldwide, ATRIAL FIBRILLATION is one of the most common causes of stroke. Researchers are now exploring the use of an investigational drug in patients with atrial fibrillation. Learn more on who can participate in the OCEANIC-AF study!
The OCEANIC-AF study is sponsored by Bayer.

Contact us for more information at 786-772-0510

Location:
Hialeah,FL
CALL US:
786-772-0510
  • Indago’s Virtual Assistant Beta

    • Virtual Assistant: Greetings, I am Indago's Virtual Assistant. Kindly note that the information I provide may not be guaranteed for accuracy. How may I help you? También hablo español y otros idiomas

    AI is thinking ...
  • Virtual Assistant
    Close
    Skip to content